Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

123.38
Delayed Data
As of Mar 24
 +0.16 / +0.13%
Today’s Change
94.42
Today|||52-Week Range
127.64
+6.59%
Year-to-Date
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valean...
Mar 22 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content
Biotech Bull Making a Comeback
Mar 21 / Zacks.com - Paid Partner Content
Amgen's Repatha Meets Primary Endpoint in Phase III Study
Mar 14 / Zacks.com - Paid Partner Content